The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
White Papers
This case study provides a review of Grady Health System’s transformation from traditional Value Analysis Joint Product Review Team structure to Va
Supply Chain Strategies & Solutions Article
The shift to bundled payments in health care continues to push the supply chain to a more central position in the overall operations and capa
Supply Chain Strategies & Solutions Article
This article is from the March/April 2017 issue of the AHRMM member-only magazine, Supply Chain Strategies & Solutions. At St.
Supply Chain Strategies & Solutions Article
Bundled payments provide a single payment for a defined episode of care that is shared among the caregivers involved in the delivery of care, with
Supply Chain Strategies & Solutions Article
The safe use of health technology—from infusion pumps to complex imaging systems—requires that healthcare facilities recognize the possibility of d
Case Studies
This is an executive summary of the case study published in the